Compare ROG & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROG | NVCR |
|---|---|---|
| Founded | 1832 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1994 | 2015 |
| Metric | ROG | NVCR |
|---|---|---|
| Price | $102.17 | $11.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $109.00 | $28.08 |
| AVG Volume (30 Days) | 132.3K | ★ 1.7M |
| Earning Date | 04-28-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.79 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $879,091,000.00 | $655,353,000.00 |
| Revenue This Year | $7.64 | $7.72 |
| Revenue Next Year | $6.09 | $6.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 7.07 | ★ 8.28 |
| 52 Week Low | $51.43 | $9.82 |
| 52 Week High | $112.81 | $20.05 |
| Indicator | ROG | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 47.76 | 45.36 |
| Support Level | $101.24 | $10.86 |
| Resistance Level | $103.15 | $13.78 |
| Average True Range (ATR) | 3.93 | 0.61 |
| MACD | -0.85 | -0.12 |
| Stochastic Oscillator | 36.47 | 15.68 |
Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.